Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction
Author(s) -
Orazio Fortunato,
Gaia Spinetti,
Claudia Specchia,
Elisa Cangiano,
Marco Valgimigli,
Paolo Madeddu
Publication year - 2013
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvt153
Subject(s) - medicine , myocardial infarction , heart failure , progenitor cell , cardiology , adverse effect , bone marrow , immunology , stem cell , biology , genetics
Following acute myocardial infarction (AMI), pro-angiogenic progenitor cells (PCs) are released from the bone marrow into the circulation and home to the ischaemic site attracted by a chemokine gradient. It is unknown if components of this early homeostatic response might help forecast the long-term clinical outcome. This study investigates if the number and migratory activity of circulating PCs predict adverse events in patients with AMI (clinical trial: NCT01271309).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom